Primary Open-Angle Glaucoma Optic Nerve Atrophy
Conditions
Interventions
Experimental Group:Methylcobalamin tablets combined with acupuncture
Sponsors
Eye & ENT Hospital Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for primary open-angle glaucoma and optic nerve atrophy; 2. After taking the medication, the intraocular pressure should be controlled within 21 MMHG. 3. Corrected visual acuity of both eyes =0.2; 4. The MD value of the visual field is =-15dB; 5. Gender is not limited. Age: 18-65 years old. 6. Voluntarily joined the trial with good compliance and signed the informed consent form.
Exclusion criteria
Exclusion criteria: Those with other eye diseases that affect visual function, such as grade III or above cataracts, retinopathy, macular degeneration, etc. 2. Underwent eye surgery within the last 6 months; 3. Those with severe systemic diseases (such as diabetes, severe cardiovascular and cerebrovascular diseases) and mental disorders; 4. Those who cannot cooperate with relevant ophthalmic examinations; 5. Those with thrombocytopenia, skin damage, ulcers, infections or scars at acupoints; 6. Women who are pregnant, planning to become pregnant or breastfeeding during the trial period; 7. Subjects who are currently participating in other research projects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Deviation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Best-Corrected Visual Acuity(BCVA);Intraocular Pressure;Retinal Nerve Fiber Layer Thickness;Visual Evoked Potential;Vision-Related Quality of Life Score;Traditional Chinese Medicine Syndrome Scoring; | — |
Countries
China
Contacts
Public ContactZhou Xingtao
Eye & ENT Hospital Fudan University
Outcome results
None listed